Psychiatry · Omaha, NE
NPI
1942314604
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
3528 Dodge St
Omaha, NE, 68131
Phone (402) 345-8828
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
2,279 services
Medicare patients, 2024
285
Average age 58
Drug cost, 2024
$1.2M
10,596 prescriptions
Company payments, 2025
$1,995
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed P Sattar was code 99213 (office e&m - established), 944 times for 128 patients. In total Syed P Sattar billed 2,279 services in 18 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 944 | 128 | $54.61 | $52K |
| 99232 Hospital E&M - Subsequent | Facility | 691 | 126 | $55.87 | $39K |
| 99238 Hospital Discharge Management | Facility | 125 | 83 | $58.21 | $7,277 |
| 99231 Hospital E&M - Subsequent | Facility | 99 | 47 | $36.08 | $3,572 |
| 99222 Hospital E&M - Initial | Facility | 93 | 59 | $89.81 | $8,353 |
| 90792 Psychotherapy - Nongroup | Facility | 89 | 88 | $121.35 | $11K |
| 90791 Psychotherapy - Nongroup | Facility | 31 | 31 | $95.29 | $2,954 |
| 99214 Office E&M - Established | Office | 27 | 16 | $80.73 | $2,180 |
| 90792 Psychotherapy - Nongroup | Office | 23 | 23 | $132.70 | $3,052 |
By year: 2022 $129K for 2,157 services; 2023 $123K for 2,099 services; 2024 $136K for 2,279 services.
Medicare prescription drug claims, 2024
In 2024, the drug Syed P Sattar prescribed most often to Medicare patients was Trazodone Hcl, with 763 prescriptions and refills. In total Syed P Sattar wrote 10,596 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trazodone Hcl Generic | 763 | 944 | 161 | $7,148 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 753 | 923 | 116 | $9,917 |
| Risperidone Generic | 583 | 681 | 91 | $5,446 |
| Haloperidol Generic | 575 | 637 | 85 | $10K |
| Topiramate Generic | 566 | 676 | 82 | $4,291 |
| Olanzapine Generic | 466 | 528 | 69 | $9,351 |
| Bupropion Xl Bupropion Hcl | 379 | 464 | 56 | $6,325 |
| Baclofen Generic | 368 | 414 | 80 | $3,816 |
| Chlorpromazine Hcl Generic | 356 | 359 | 39 | $57K |
| Naltrexone Hcl Generic | 355 | 396 | 59 | $24K |
| Clonazepam Generic | 346 | 355 | 44 | $2,133 |
| Duloxetine Hcl Generic | 323 | 434 | 56 | $5,618 |
| Lorazepam Generic | 248 | 265 | 32 | $1,327 |
| Prazosin Hcl Generic | 236 | 270 | 41 | $3,426 |
| Aripiprazole Generic | 229 | 289 | 55 | $15K |
Brand drugs: - claims; generic drugs: 10,117 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed P Sattar $1,995 ($1,995 in general payments such as food, travel and fees) from 12 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $394.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 27 | $394 |
| Neurocrine BioSciences, Inc. NBIX | 19 | $290 |
| Abbvie Inc. ABBV | 19 | $274 |
| Vanda Pharmaceuticals Inc. VNDA | 11 | $263 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $196 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 7 | $157 |
| Alkermes, Inc. ALKS | 7 | $136 |
| Harmony Biosciences LLC HRMY | 3 | $93.79 |
| Janssen Pharmaceuticals, Inc JNJ | 3 | $56.13 |
| Axsome Therapeutics, Inc. AXSM | 3 | $49.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.